Patents by Inventor Elina HARONSKY

Elina HARONSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170231927
    Abstract: The present invention relates to oral dosage forms comprising Memantine or a pharmaceutically acceptable salt thereof, pharmaceutical formulations comprising the oral dosage forms, and methods for treating mild, moderate or severe Alzheimer's dementia, or neuropathic pain comprising the oral dosage forms and formulations.
    Type: Application
    Filed: May 1, 2017
    Publication date: August 17, 2017
    Inventors: ELENA KAGAN, NITZAN SHAHAR, ELINA HARONSKY, GREGG R. DEROSA
  • Publication number: 20160199396
    Abstract: The present invention relates to an oral unit dosage form comprising Emtricitabine, Tenofovir, Darunavir and Ritonavir and a monolithic tablet comprising Darunavir and Ritonavir and their use to treat HIV infection.
    Type: Application
    Filed: February 23, 2016
    Publication date: July 14, 2016
    Applicant: TEVA Pharmaceutical Industries Ltd.
    Inventors: Nitzan SHAHAR, Elina HARONSKY, Julia HRAKOVSKY
  • Publication number: 20140050784
    Abstract: The present invention relates to oral dosage forms comprising Memantine or a pharmaceutically acceptable salt thereof, pharmaceutical formulations comprising the oral dosage forms, and methods for treating mild, moderate or severe Alzheimer's dementia, or neuropathic pain comprising the oral dosage forms and formulations.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 20, 2014
    Applicants: TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Elena KAGAN, Nitzan SHAHAR, Elina HARONSKY, Gregg R. DEROSA
  • Publication number: 20120301541
    Abstract: A compressed core for a pharmaceutical dosage form comprising a mixture of (a) at least one pharmaceutically acceptable organic acid, and (b) at least one pharmaceutically acceptable excipient is described. Such compressed core is useful for the preparation of pharmaceutical compositions containing a drug in which dissolution of the drug is favored in acidic environments. Also described are pharmaceutical compositions comprising such compressed core.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 29, 2012
    Inventors: Elina HARONSKY, Dafna Arieli